Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

M. Juan | P. Soler-Palacín | A. Zabalza | M. Rosenfeld | E. Martínez-Heras | C. Montejo | A. Saiz | S. Llufriu | H. Ariño | E. Martinez-Hernandez | J. Dalmau | G. Aznar-Laín | C. Fortuny | E. Rodríguez-Rodríguez | L. Querol | A. Vlagea | F. Graus | L. Alsina | M. Toledo | D. Campos | P. Bellas-Lamas | E. López‐Laso | T. Armangué | M. Spatola | L. Bataller | J. Muchart | J. Fernández-Ramos | S. Sarria-Estrada | L. Abraira | David Dacruz-Álvarez | M. Erro | O. Neth | S. Aguilera-Albesa | V. Cantarín-Extremera | V. González-Álvarez | M. Martínez-González | M. Marcos | I. Martí-Carrera | L. Prieto | S. Guillén | M. Dapena | A. Noguera-Julian | V. Pomar | V. Soto-Insuga | N. Núñez-Enamorado | A. Camacho | R. Guerri | J. García-Moncó | G. Morís | E. Fernández-Cooke | M. Cárceles-Cordon | X. Martínez-Lacasa | A. Arjona-Padillo | Simone Mattozzi | M. Tomás | A. Campo | E. Turón | I. Corral-Corral | M. Madruga | Luisa Arrabal | A. Moreira | C. Sierra | A. Deya | A. Hedrera-Fernandez | T. Gili | María López | M. C. Miranda-Herrero | L. Martín-Viota | A. Felipe | D. Conejo-Moreno | B. Muñoz-Cabello | Luis Monros-Giménez | Gabriela Secondi | Alfonso Amado-Puentes | Izascun Arratibel | Teresa Bermejo | Sabas Boyero-Durán | Cristobal Carnero | V. Delgadillo-Chilavert | Jordi Estela-Herrero | María Lorenzo-Ruiz | I. Málaga-Diéguez | Leticia Martín Gil | L. Monge | Juan Navarro-Morón | Juan C Portillo-Cuenca | M. Poyato | Laura Toledo-Bravo | Carmen Torres-Torres | M. Lorenzo-Ruiz | T. Bermejo | E. López-Laso | M. Carceles-Cordon | Antia Moreira | E. Martínez-Hernandez

[1]  E. Aurelius,et al.  Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  V. Wong,et al.  Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong , 2018, Brain and Development.

[3]  M. Dalakas,et al.  Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy , 2018, Therapeutic advances in neurological disorders.

[4]  M. Rosenfeld,et al.  Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor , 2018, Neurology.

[5]  D. Lynch,et al.  Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection , 2018, Neurology: Neuroimmunology & Neuroinflammation.

[6]  W. Lieb,et al.  Genetic predisposition in anti‐LGI1 and anti‐NMDA receptor encephalitis , 2018, Annals of neurology.

[7]  S. Rheims,et al.  Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis. , 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[8]  A. Frigo,et al.  Herpes simplex virus‐induced anti‐N‐methyl‐d‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases , 2017, Developmental medicine and child neurology.

[9]  R. Whitley,et al.  Herpes Simplex Encephalitis: an Update , 2017, Current Infectious Disease Reports.

[10]  K. Chu,et al.  Anti‐LGI1 encephalitis is associated with unique HLA subtypes , 2017, Annals of neurology.

[11]  K. Rostásy,et al.  Autoimmune post–herpes simplex encephalitis of adults and teenagers , 2015, Neurology.

[12]  J. Bale,et al.  Relapse in herpes simplex virus encephalitis , 2015, Neurology.

[13]  F. Ducray,et al.  Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis , 2014, Neurology.

[14]  J. Dalmau,et al.  Herpes simplex virus encephalitis is a trigger of brain autoimmunity , 2014, Annals of neurology.

[15]  R. Dale,et al.  Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N‐Methyl‐D‐aspartate receptor or dopamine‐2 receptor , 2014, Movement disorders : official journal of the Movement Disorder Society.

[16]  A. Vincent,et al.  N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse , 2014, Movement disorders : official journal of the Movement Disorder Society.

[17]  J. Paolicchi.  The timing of pediatric epilepsy syndromes: What are the developmental triggers? , 2013, Annals of the New York Academy of Sciences.

[18]  R. Balice-Gordon,et al.  Late-onset anti–NMDA receptor encephalitis , 2013, Neurology.

[19]  N. Boddaert,et al.  Children often present with infantile spasms after herpetic encephalitis , 2013, Epilepsia.

[20]  J. Dalmau,et al.  Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. , 2013, The Journal of pediatrics.

[21]  L. Honig,et al.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study , 2013, The Lancet Neurology.

[22]  C. Ploner,et al.  N‐methyl‐D‐aspartate receptor antibodies in herpes simplex encephalitis , 2012, Annals of neurology.

[23]  J. Horváth,et al.  Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis , 2011, Neurology.

[24]  E. Boltshauser,et al.  Acute ischemic stroke in children versus young adults , 2011, Annals of neurology.

[25]  Abdelmonem A. Afifi,et al.  Practical Multivariate Analysis , 2011 .

[26]  D. Kullmann,et al.  N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes , 2010, Brain : a journal of neurology.

[27]  M. Rosenfeld,et al.  Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents , 2009, Annals of neurology.

[28]  T. Baram,et al.  Febrile seizures: Mechanisms and relationship to epilepsy , 2009, Brain and Development.

[29]  Xiaoyu Peng,et al.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies , 2008, The Lancet Neurology.

[30]  B. Sköldenberg,et al.  Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[32]  L. Hagberg,et al.  Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults , 2006, Journal of Neurology.

[33]  G. Ponsot,et al.  Herpes simplex encephalitis relapses in children , 2003, Neurology.

[34]  D. Webb,et al.  Movement disorders in association with herpes simplex virus encephalitis in children: a review , 1998, Developmental medicine and child neurology.

[35]  P. Lebon,et al.  Relapse of Herpes Simplex Encephalitis , 1995, Journal of child neurology.

[36]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[37]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[38]  C. A. Phillips,et al.  Herpes Simplex Encephalitis , 1966, Lancet.

[39]  S. Sekaran,et al.  Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. , 2018, Acta virologica.

[40]  T. Morishima,et al.  Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.